Ionis Pharmaceuticals (IONS)
$42.08
1.01 (2.46%)
IONS Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
5.97B
PE Ratio
-91.48
EPS
-0.46
Volume (Avg. Vol.)
379,705
Day's Range
$40.90 - $42.25
52-Week Range
$34.32 - $54.44
Dividend & Yield
N/A (N/A)
IONS Stock Predictions, Articles, and Ionis Pharmaceuticals News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about!
DDD, AONE, RAVN, ION: 4 Stocks That Cathie Wood’s ARK Funds Are Betting On Today
Cathie Wood's Ark Invest continues to add more shares to its holdings with it picking out a few companies worth noting on Wednesday.
Akcea Therapeutics News: AKCA Stock Rockets on Pfizer Licensing Deal
Akcea Therapeutics (AKCA) stock is flying high on Monday following news of a $250 million deal with Pfizer (NYSE:PFE) for licensing rights.
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
Why Every Investor Should Hold Shares of Biogen Stock
Biogen reported solid study results for its Alzheimer's study and followed up with a solid quarterly earnings report. BIIB stock is a clear core holding for investors.
10 Ionis Pharmaceuticals Inc Earnings Highlights
Ionis Pharmaceuticals (IONS) released its earnings report for the first quarter of 2018 on Friday and 'InvestorPlace' has some highlights from it.
9 More Stocks Still Growing Faster Than Amazon
If you're looking for growth, Amazon.com isn't your only investment choice. These names are on a tear as well, and could be worthy additions to your portfolio.
Ionis Pharmaceuticals Inc (IONS) Shares Fall on Drug Safety Concerns
Ionis Pharmaceuticals (IONS) stock was down on Monday on safety concerns for its drug inotersen following results from a phase 3 study.
Ionis Pharmaceuticals Inc (IONS) Stock Dips on Goldman Sachs Downgrade
Ionis Pharmaceuticals (IONS) shares were plummeting Friday as the stock received a downgrade from Goldman Sachs following its disastrous Monday.
Hottest Manufacturing Stocks Now – MBRX ZYNE SID ONVO
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
37 Biotechnology Stocks to Sell Now
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
